Cardiology
Levosimendan PSK
Registration certificate:
INN:
Levosimendan
Release form:
Concentrate for solution for infusion
Therapeutic Area:
Cardiology
Pharmacotherapeutic Group:
Cardiotonic agent of non-glycoside structure
Conditions for dispensing:
On prescription
Packaging:

Indications:

Levosimendan PSK is indicated for short-term treatment of acute decompensated severe chronic heart failure in adults when conventional therapy is inadequate and there is a need to restore myocardial contractility.

Quality control
at all stages of production